With so many people using at-home COVID-19 tests, if they're testing at all, experts acknowledged long ago that the true number of cases is higher than what is officially reported.
Aug 22, 2022
0
29
Many people have contracted COVID at least three times, yet around 3 in 20 Brits have never caught it at all. A leading testing expert reveals whether vaccines, lifestyle or blood group are the key to their escape.
Aug 19, 2022
0
18
New coronavirus cases reported globally dropped nearly a quarter in the last week while deaths fell 6% but were still higher in parts of Asia, according to a report Thursday on the pandemic by the World Health Organization.
Aug 18, 2022
0
12
The majority of people who were likely infected with the omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn't know they had the virus, according to a new study from Cedars-Sinai investigators. The findings ...
Aug 17, 2022
1
100
The UK's drug regulator said Monday it had approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.
Aug 15, 2022
0
4
The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech COVID vaccine adapted for two fast-spreading subvariants of the Omicron strain.
Aug 10, 2022
0
50
A model of COVID-19 dynamics in South Africa reveals epidemiological characteristics of the main SARS-CoV-2 variants of concern and highlights their potential to cause further outbreaks. Published in eLife, the researchers' ...
Aug 10, 2022
0
29
Researchers at Karolinska Institutet present the results of a refined clinical COVID-19 test, which has been used to track the spread of the omicron variant in real time in the Swedish population. The study, published in ...
Aug 10, 2022
0
59
More mutations have been carried by the SARS-CoV-2 omicron variant than previously reported variants. However, the genetic differentiation and diversity within omicron variant that occurs during its early spread remains unclear.
Aug 5, 2022
0
19
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers ...
Aug 1, 2022
0
37
